ACCENTIA BIOPHARMACEUTICALS INC Share-based Payment Arrangement, Expense
ACCENTIA BIOPHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $3.70 million for the 9-month period ending 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2012-08-14
- 2012-06-30: Share-based Payment Arrangement, Expense 9 month $3.70M.
- 2011-06-30: Share-based Payment Arrangement, Expense 9 month $16.00M.
| Period end | Share-based Payment Arrangement, Expense 9 month |
|---|---|
| 2012-06-30 | $3.70M 10-Q · filed 2012-08-14 |
| 2011-06-30 | $16.00M 10-Q · filed 2012-08-14 |